BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 28004444)

  • 1. Changing survival of people with myeloma and end stage kidney disease: A cohort study using Australian and New Zealand dialysis and transplant registry 1963-2013.
    Webster AC; Irish AB; Kelly PJ
    Nephrology (Carlton); 2018 Mar; 23(3):217-225. PubMed ID: 28004444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
    Zhang L; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; De Zoysa J; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
    Nephrology (Carlton); 2016 May; 21(5):387-96. PubMed ID: 26393772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis.
    Decourt A; Gondouin B; Delaroziere JC; Brunet P; Sallée M; Burtey S; Dussol B; Ivanov V; Costello R; Couchoud C; Jourde-Chiche N
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):431-41. PubMed ID: 26728585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases.
    Mallett A; Tang W; Clayton PA; Stevenson S; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Johnson DW
    Nephrol Dial Transplant; 2014 Dec; 29(12):2277-86. PubMed ID: 25061124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absolute risk and risk factors for stroke mortality in patients with end-stage kidney disease (ESKD): population-based cohort study using data linkage.
    De La Mata NL; Alfaro-Ramirez M; Kelly PJ; Masson P; Al-Shahi Salman R; Webster AC
    BMJ Open; 2019 Feb; 9(2):e026263. PubMed ID: 30798318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient survival on haemodiafiltration and haemodialysis: a cohort study using the Australia and New Zealand Dialysis and Transplant Registry.
    See EJ; Hedley J; Agar JWM; Hawley CM; Johnson DW; Kelly PJ; Lee VW; Mac K; Polkinghorne KR; Rabindranath KS; Sud K; Webster AC
    Nephrol Dial Transplant; 2019 Feb; 34(2):326-338. PubMed ID: 30124954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compared with younger peritoneal dialysis patients, elderly patients have similar peritonitis-free survival and lower risk of technique failure, but higher risk of peritonitis-related mortality.
    Lim WH; Dogra GK; McDonald SP; Brown FG; Johnson DW
    Perit Dial Int; 2011; 31(6):663-71. PubMed ID: 21632440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for Stroke in People with End-Stage Kidney Disease: A Cohort Study.
    Masson P; Kotwal S; Kelly PJ; Craig JC; Lindley RI; Gallagher M; Cass A; Webster AC
    Cerebrovasc Dis; 2016; 42(5-6):428-438. PubMed ID: 27505159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and survival of end-stage kidney disease due to polycystic kidney disease in Australia and New Zealand (1963-2014).
    Fernando MR; Dent H; McDonald SP; Rangan GK
    Popul Health Metr; 2017 Feb; 15(1):7. PubMed ID: 28212688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End-stage kidney disease due to haemolytic uraemic syndrome--outcomes in 241 consecutive ANZDATA registry cases.
    Tang W; Mohandas J; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Wiggins KJ; Bannister KM; Campbell SB; Johnson DW
    BMC Nephrol; 2012 Dec; 13():164. PubMed ID: 23206870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodialysis withdrawal in Australia and New Zealand: a binational registry study.
    Chan S; Marshall MR; Ellis RJ; Ranganathan D; Hawley CM; Johnson DW; Wolley MJ
    Nephrol Dial Transplant; 2020 Apr; 35(4):669-676. PubMed ID: 31397483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Predictors and Causes of Technique Failure Within the First Year of Peritoneal Dialysis: An Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) Study.
    See EJ; Johnson DW; Hawley CM; Pascoe EM; Badve SV; Boudville N; Clayton PA; Sud K; Polkinghorne KR; Borlace M; Cho Y
    Am J Kidney Dis; 2018 Aug; 72(2):188-197. PubMed ID: 29277508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. End-Stage Kidney Disease Due to Fibrillary Glomerulonephritis and Immunotactoid Glomerulopathy - Outcomes in 66 Consecutive ANZDATA Registry Cases.
    Mallett A; Tang W; Hart G; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Clayton PA; Johnson DW
    Am J Nephrol; 2015; 42(3):177-84. PubMed ID: 26418732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of patients with end-stage kidney disease due to membranoproliferative glomerulonephritis: an ANZDATA registry study.
    Wilson GJ; Cho Y; Teixiera-Pinto A; Isbel N; Campbell S; Hawley C; Johnson DW
    BMC Nephrol; 2019 Nov; 20(1):417. PubMed ID: 31752734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of end-stage kidney disease for patients with lupus nephritis.
    Zhang L; Lee G; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
    Kidney Int; 2016 Jun; 89(6):1337-45. PubMed ID: 27165824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low socio-economic status adversely effects dialysis survival in Australia.
    Krishnasamy R; Gray NA
    Nephrology (Carlton); 2018 May; 23(5):453-460. PubMed ID: 28383177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005).
    Villar E; Chang SH; McDonald SP
    Diabetes Care; 2007 Dec; 30(12):3070-6. PubMed ID: 17848610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demography and survival of patients receiving treatment for chronic renal failure in Australia and New Zealand: report on dialysis and renal transplantation treatment from the Australia and New Zealand Dialysis and Transplant Registry.
    Disney AP
    Am J Kidney Dis; 1995 Jan; 25(1):165-75. PubMed ID: 7810521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk.
    Lim WH; Johnson DW; Hawley C; Lok C; Polkinghorne KR; Roberts MA; Boudville N; Wong G
    Med J Aust; 2018 Nov; 209(10):440-446. PubMed ID: 30332936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in Incidence of ESKD in People With Type 1 and Type 2 Diabetes in Australia, 2002-2013.
    Koye DN; Magliano DJ; Reid CM; Pavkov ME; Chadban SJ; McDonald SP; Polkinghorne KR; White S; Paul C; Shaw JE
    Am J Kidney Dis; 2019 Mar; 73(3):300-308. PubMed ID: 30579709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.